CCR8 antagonist 1
≥98%
- Product Code: 163926
CAS:
723304-76-5
| Molecular Weight: | 495.59 g./mol | Molecular Formula: | C₂₆H₂₉N₃O₅S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in immunological research to modulate T cell activity, particularly targeting regulatory T cells (Tregs) involved in immune suppression. Shows potential in cancer immunotherapy by inhibiting CCR8-mediated recruitment of Tregs to tumor sites, thereby enhancing anti-tumor immune responses. Also investigated for use in inflammatory and autoimmune diseases where CCR8 signaling plays a role in disease progression. Enables selective blockade of chemokine signaling to study immune cell migration and function in vitro and in vivo.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿26,000.00 |
+
-
|
CCR8 antagonist 1
Used in immunological research to modulate T cell activity, particularly targeting regulatory T cells (Tregs) involved in immune suppression. Shows potential in cancer immunotherapy by inhibiting CCR8-mediated recruitment of Tregs to tumor sites, thereby enhancing anti-tumor immune responses. Also investigated for use in inflammatory and autoimmune diseases where CCR8 signaling plays a role in disease progression. Enables selective blockade of chemokine signaling to study immune cell migration and function in vitro and in vivo.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :